Like every person, every tumour is unique. Molecular information and genomic analysis play an increasingly important role in personalised treatment, especially for cancer patients.
Foundation Medicine Inc is a molecular insights company that provides information to physicians and their patients through a deep understanding of the molecular changes that contribute to diseases such as cancer.
Foundation Medicine offers a full suite of comprehensive genomic profiling (CGP) assays to identify the molecular alterations in an individual patient's cancer and match them with relevant targeted therapies, immunotherapies and clinical trials.
In Ireland, Roche’s pharmaceutical division is the licensed distributor of FoundationOne® CDx and FoundationOne®Liquid CDx for patients with solid tumours, as well as FoundationOne® Heme for patients with sarcomas or haematological cancers including leukaemia, lymphoma and myeloma.
Healthcare Professionals - for further information or to place an order
For Healthcare professionals seeking more information, visit https://www.foundationmedicine.ie/public/home/references.html
Only medical doctors are able to order a Foundation Medicine test. Healthcare professionals who would like more information about Roche Foundation Medicine services may go to https://www.foundationmedicine.ie/ , contact Roche Products (Ireland) Ltd Ireland Ltd or email [email protected]
Orders are placed via the online ordering portal by medical doctors using the following link: https://www.foundationmedicine.ie/order-now.html
For any assistance in registering with the portal please contact [email protected]
M-IE-00001587 DOP 13.7.23
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.